8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

The Effect of Combined Exposure of 900MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells.

Bioeffects Seen

Jin Z, Zong C, Jiang B, Zhou Z, Tong J, Cao Y. · 2012

View Original Abstract
Share:

Low-level cell phone frequency radiation unexpectedly protected cancer cells from chemotherapy damage, revealing complex biological responses to RF exposure.

Plain English Summary

Summary written for general audiences

Researchers exposed human leukemia cells to cell phone-frequency radiation, then treated them with chemotherapy. Surprisingly, cells receiving radiation first showed better survival and less damage than those getting chemotherapy alone, suggesting low-level RF exposure might protect against certain cellular damage.

Why This Matters

This study presents a fascinating paradox in EMF research that challenges our understanding of how radiofrequency radiation affects living cells. The finding that 900 MHz RF exposure at 12 µW/cm² - a power density well within everyday cell phone exposure levels - appears to protect cells from chemotherapy damage runs counter to the typical narrative about RF harm. The science demonstrates that biological responses to EMF are far more complex than simple dose-response relationships might suggest. What this means for you is that the cellular effects of RF exposure aren't necessarily straightforward or universally negative. However, this protective effect was observed specifically against a highly toxic chemotherapy drug, not against normal cellular processes. The reality is that this type of hormetic response (where low doses of a stressor provide protection) has been documented with other environmental exposures, but it doesn't negate the broader body of research showing potential health risks from chronic RF exposure in other contexts.

Exposure Details

Power Density
0.12 µW/m²
Source/Device
900MHz
Exposure Duration
1 hour/day for 3 days

Exposure Context

This study used 0.12 µW/m² for radio frequency:

Building Biology guidelines are practitioner-based limits from real-world assessments. BioInitiative Report recommendations are based on peer-reviewed science. Check Your Exposure to compare your own measurements.

Where This Falls on the Concern Scale

Study Exposure Level in ContextStudy Exposure Level in ContextThis study: 0.12 µW/m²Extreme Concern - 1,000 uW/m2FCC Limit - 10M uW/m2Effects observed in the Slight Concern rangeFCC limit is 83,333,333x higher than this level
A logarithmic frequency spectrum from 10 Hz to 100 GHz showing where this study's 900 MHz exposure sits relative to common EMF sources.Where This Frequency Sits on the EMF SpectrumELFVLFLF / MFHF / VHFUHFSHFmm10 Hz100 GHzThis study: 900 MHzPower lines50/60 Hz5G mm28 GHzLogarithmic scale

Study Details

The aim of this study is to investigate The Effect of Combined Exposure of 900MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells.

Human promyelocytic leukemia HL-60 cells were pre-exposed to non-ionizing 900 MHz radiofrequency fie...

The results obtained in un-exposed and sham-exposed control cells were compared with those exposed t...

Thus, RF pre-exposure appear to protect the HL-60 cells from the toxic effects of subsequent treatment with DOX. These observations were similar to our earlier data which suggested that pre-exposure of mice to 900 MHz RF at 120 µW/cm2 power density for 1 hours/day for 14 days had a protective effect in hematopoietic tissue damage induced by subsequent gamma-irradiation.

Cite This Study
Jin Z, Zong C, Jiang B, Zhou Z, Tong J, Cao Y. (2012). The Effect of Combined Exposure of 900MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells. PLoS One.7(9):e46102, 2012.
Show BibTeX
@article{z_2012_the_effect_of_combined_1050,
  author = {Jin Z and Zong C and Jiang B and Zhou Z and Tong J and Cao Y.},
  title = {The Effect of Combined Exposure of 900MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells.},
  year = {2012},
  
  url = {https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0046102},
}

Quick Questions About This Study

A 2012 study found that exposing leukemia cells to 900MHz radiation before chemotherapy actually increased cell survival and reduced damage compared to chemotherapy alone. This suggests low-level RF exposure might offer protective effects against certain cellular toxins, though more research is needed.
Research on human leukemia cells showed that 900MHz radiation alone caused no significant cellular damage or death. However, when cells received this radiation before chemotherapy treatment, they showed better survival rates and less toxic damage than untreated cells receiving chemotherapy.
A cellular study found that 900MHz radiation by itself caused no harmful effects to human leukemia cells. Cell viability, death rates, and cellular function remained normal. The radiation only showed effects when combined with chemotherapy, where it appeared protective rather than harmful.
Pre-exposure to 900MHz radiofrequency radiation appeared to reduce chemotherapy toxicity in laboratory cells. Cells receiving RF before chemotherapy showed increased survival, less cell death, and better cellular function compared to cells treated with chemotherapy alone, suggesting potential protective interactions.
Laboratory testing of 900MHz radiation on human leukemia cells showed no direct harmful effects. Cell survival, death rates, and key cellular functions remained unchanged. The radiation only demonstrated biological effects when combined with chemotherapy drugs, where it reduced cellular damage.